[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2003275838A1 - Pyrrolidin-2-on derivatives as ep4 receptor agonists - Google Patents

Pyrrolidin-2-on derivatives as ep4 receptor agonists

Info

Publication number
AU2003275838A1
AU2003275838A1 AU2003275838A AU2003275838A AU2003275838A1 AU 2003275838 A1 AU2003275838 A1 AU 2003275838A1 AU 2003275838 A AU2003275838 A AU 2003275838A AU 2003275838 A AU2003275838 A AU 2003275838A AU 2003275838 A1 AU2003275838 A1 AU 2003275838A1
Authority
AU
Australia
Prior art keywords
pyrrolidin
derivatives
receptor agonists
agonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003275838A
Other versions
AU2003275838A8 (en
Inventor
Zavier Billot
Mario Girard
Yongxin Han
Marie-Claire Wilson
Robert N. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Publication of AU2003275838A1 publication Critical patent/AU2003275838A1/en
Publication of AU2003275838A8 publication Critical patent/AU2003275838A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003275838A 2002-10-25 2003-10-23 Pyrrolidin-2-on derivatives as ep4 receptor agonists Abandoned AU2003275838A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42150302P 2002-10-25 2002-10-25
US60/421,503 2002-10-25
PCT/CA2003/001618 WO2004037813A1 (en) 2002-10-25 2003-10-23 Pyrrolidin-2-on derivatives as ep4 receptor agonists

Publications (2)

Publication Number Publication Date
AU2003275838A1 true AU2003275838A1 (en) 2004-05-13
AU2003275838A8 AU2003275838A8 (en) 2004-05-13

Family

ID=32176723

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003275838A Abandoned AU2003275838A1 (en) 2002-10-25 2003-10-23 Pyrrolidin-2-on derivatives as ep4 receptor agonists

Country Status (2)

Country Link
AU (1) AU2003275838A1 (en)
WO (1) WO2004037813A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7547685B2 (en) 2004-11-08 2009-06-16 Allergan, Inc. Therapeutic substituted pyrrolidone compounds
ES2388929T3 (en) 2005-03-10 2012-10-19 Allergan, Inc. Gamma - substituted lactams as therapeutic agents
AU2012211448B2 (en) * 2005-03-10 2016-01-07 Allergan, Inc. Substituted gamma lactams as therapeutic agents
US7893107B2 (en) 2005-11-30 2011-02-22 Allergan, Inc. Therapeutic methods using prostaglandin EP4 agonist components
UY30121A1 (en) 2006-02-03 2007-08-31 Glaxo Group Ltd NEW COMPOUNDS
US7592364B2 (en) 2006-02-28 2009-09-22 Allergan, Inc. Substituted gamma lactams as therapeutic agents
EP1996546B1 (en) * 2006-03-20 2014-11-26 Allergan, Inc. Substituted gamma lactams as prostaglandin ep2 agonists
UA98772C2 (en) 2006-06-23 2012-06-25 Эбботт Леборетриз Cyclopropyl amine derivatives as histamin h3 receptor modulators
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
ATE502914T1 (en) 2006-08-09 2011-04-15 Allergan Inc THERAPEUTIC AMIDES AND CORRESPONDING COMPOUNDS
CA2669763C (en) 2006-11-16 2015-02-17 Bayer Schering Pharma Aktiengesellschaft Ep2 and ep4 agonists as agents for the treatment of influenza a viral infection
WO2008071736A1 (en) 2006-12-15 2008-06-19 Glaxo Group Limited Benzamide derivatives as ep4 receptor agonists
AU2008216499B2 (en) * 2007-02-15 2014-04-17 Allergan, Inc. Gamma-lactams for the treatment of glaucoma or elevated intraocular pressure
GB0721611D0 (en) 2007-11-02 2007-12-12 Glaxo Group Ltd Novel compounds
EP2291368B1 (en) 2008-04-24 2012-12-19 Allergan, Inc. Substituted gamma lactams as therapeutic agents
EP2149551A1 (en) 2008-07-30 2010-02-03 Bayer Schering Pharma AG N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors
EP2149554A1 (en) 2008-07-30 2010-02-03 Bayer Schering Pharma Aktiengesellschaft Indolyamides as modulators for an EP2 receptor
EP2149552A1 (en) 2008-07-30 2010-02-03 Bayer Schering Pharma AG 5,6 substituted benzamide derivatives as modulators of EP2 receptors
US7985765B2 (en) 2008-08-20 2011-07-26 Allergan, Inc. Therapeutic substituted pyrroles
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
US8853390B2 (en) 2010-09-16 2014-10-07 Abbvie Inc. Processes for preparing 1,2-substituted cyclopropyl derivatives
CN107304452A (en) * 2016-04-25 2017-10-31 复旦大学 BK channel proteins are preparing the purposes during osteoblastic proliferation intervenes medicine extremely

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2346706A1 (en) * 1973-09-17 1975-04-03 Hoechst Ag NEW, NON NATURALLY OCCURRING ANALOGS OF PROSTANIC ACIDS AND THE PROCESS FOR THEIR PRODUCTION
CN1476429A (en) * 2000-11-27 2004-02-18 �Ʒ� EP4 receptor selective agonists in treatment of osteoporosis
KR20070087078A (en) * 2001-07-23 2007-08-27 오노 야꾸힝 고교 가부시키가이샤 Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
CN1653046A (en) * 2002-03-05 2005-08-10 小野药品工业株式会社 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient

Also Published As

Publication number Publication date
WO2004037813A1 (en) 2004-05-06
AU2003275838A8 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
AU2003275838A1 (en) Pyrrolidin-2-on derivatives as ep4 receptor agonists
AU2003255492A1 (en) Heterocyclic derivatives
AU2003260345A1 (en) 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
AU2003290700A1 (en) Farnesoid x receptor agonists
AU2003245700A1 (en) Pyrazolopyridine derivatives
PL376396A1 (en) Indole derivatives as beta-2 agonists
EP1682493B8 (en) Amidoacetonitrile derivatives
AU2003243637A1 (en) Cannabinoid receptor agonists
PL373410A1 (en) Substituted indoles as alpha-1 agonists
AU2003263424A1 (en) Imidazopyridine compunds as 5-ht4 receptor agonists
AU2003281477A1 (en) 4-amino-substituted pyrimidine derivatives
PL378342A1 (en) 2-piperidone derivatives as prostaglandin agonists
EP1606277B8 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
PL376920A1 (en) Substituted 4-alkoxyoxazol derivatives as ppar agonists
AU2003231805A1 (en) Purine derivatives as liver x receptor agonists
AU2003301968A1 (en) 4-aminomethyl-1-aryl-cyclohexylamine derivatives
AU2003280838A1 (en) Indole derivatives as somatostatin agonists or antagonists
AU2003278369A1 (en) 3-cyano-quinoline derivatives
AU2003303648A1 (en) Novel 5-hydroxyindole-3-carboxylate derivatives
EP1706373B8 (en) Amidoacetonitrile derivatives
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
AU2003301299A1 (en) Benzyl substituted (piperidin-4-yl) aminobenzamido derivatives as delta-opiod receptor modulators
AU2003248356A1 (en) Beta3-adrenergic receptor agonists
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2002356369A1 (en) Xanthine derivatives as muscarinic receptor antagonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase